Testing a New Treatment for Moderate to Severe Skin Eczema

This study is testing a new medication called ARQ-234 to see if it is safe and helps people with moderate to severe eczema. The trial has three parts: first, researchers will give single doses to healthy volunteers and people with eczema to understand how the body handles the medication; second, they will give multiple doses to people with eczema; and third, they will expand testing in a larger group with eczema. The goal is to learn whether this treatment could help people whose eczema has not improved with current therapies.

Many people with moderate to severe eczema don't respond well to existing treatments or can't tolerate them. This trial exists to evaluate whether this new medication could offer a better option for these patients who have limited alternatives.